🔥🐔 BizChicken 🐔🔥
Companies Similar to Peak Bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Allakos Inc.
lirentelimab (AK002)
Allakos Inc. is a clinical stage biopharmaceutical company that develops therapeutics targeting immunomodulatory receptors on immune cells for allergy, inflammatory, and proliferative diseases.
Symbol: ALLK
Recent Price: $1.19
Industry: Biotechnology
CEO: Dr. Robert Alexander Ph.D.
Sector: Healthcare
Employees: 131
Address: 975 Island Drive, Redwood City, CA 94065
Phone: 650 597 5002
Leadership
- Robert Alexander, PhD, Chief Executive Officer
- Robert Andreatta, CFA, Vice President, Controller
- Neil Graham, MD, Chief Medical Officer
- Steven James, Biopharma Executive
- Amy Ladd, MD, Professor of Orthopaedic Surgery
- Dolca Thomas, MD, Venture Partner
- Paul Walker, CFA, Partner
Last updated: 2024-12-31
Bio-Path Holdings, Inc.
DNAbilize
Bio-Path Holdings, Inc. is a clinical and preclinical stage oncology focused RNAi nano particle drug development company, developing products based on the DNAbilize technology. The company is advancing its lead drug candidate, prexigebersen, for the treatment of AML and myelodysplastic syndrome.
Symbol: BPTH
Recent Price: $1.17
Industry: Biotechnology
CEO: Mr. Peter H. Nielsen MBA
Sector: Healthcare
Employees: 10
Address: 4710 Bellaire Boulevard, Bellaire, TX 77401
Phone: 832 742 1357
Leadership
- Peter Nielsen, Chief Executive Officer, Chief Financial Officer
- Ana Tari Ashizawa, PhD, MBA, Senior Vice President of Research, Development & Clinical Design
- Anthony Price, MBA, Senior Vice President of Finance, Accounting & Administration
- Michael Hickey, MBA, Vice President of Clinical Operations
- Michael Roberts, Director of Manufacturing Planning & Engineering
- Chairman of the Board,
- President,
- Heath Cleaver, Director
- Paul Aubert, Director
- Douglas P. Morris, Director
- Aline Sherwood, Director
Last updated: 2024-12-31
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Royalty Pharma plc
biopharmaceutical royalties
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry, collaborating with various partners to acquire royalties on marketed and development-stage therapies in multiple therapeutic areas.
Contact | Contact | About | About | News | About | About | News | About | About | About | About
Symbol: RPRX
Recent Price: $25.32
Industry: Biotechnology
CEO: Mr. Pablo Gerardo Legorreta
Sector: Healthcare
Employees: 75
Address: 110 East 59th Street, New York, NY 10022
Phone: 212 883 0200
Last updated: 2024-12-31
Alto Neuroscience, Inc.
ALTO-100, ALTO-300, ALTO-101, ALTO-203, ALTO-202
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company specializing in psychiatry drug development, with a range of innovative treatments targeting major depressive disorder and cognitive impairments.
Symbol: ANRO
Recent Price: $4.20
Industry: Biotechnology
CEO: Dr. Amit Etkin M.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 369 South San Antonio Road, Los Altos, CA 94022
Phone: (650) 200-0412
Last updated: 2024-12-31
BioVie Inc.
BIV201, NE3107
Bio Vie Inc., a clinical stage biotechnology company, focuses on discovering, developing, and commercializing drug therapies in the United States, with products targeting liver cirrhosis, Alzheimer's, Parkinson's, multiple myeloma, and prostate cancer.
Symbol: BIVI
Recent Price: $2.09
Industry: Biotechnology
CEO: Mr. Cuong Viet Do M.B.A.
Sector: Healthcare
Employees: 14
Address: 680 West Nye Lane, Carson City, NV 89703
Phone: 775 888 3162
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Day One Biopharmaceuticals, Inc.
DAY101
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for genetically defined cancers. Their lead product candidate is DAY101, currently in Phase II clinical trials for pediatric patients with low-grade glioma.
Vision/Values | Leadership | About | Contact | About | Leadership | Leadership | Leadership | Leadership | Leadership | About | About
Symbol: DAWN
Recent Price: $12.58
Industry: Biotechnology
CEO: Dr. Jeremy Bender M.B.A., Ph.D.
Sector: Healthcare
Employees: 174
Address: 395 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 484 0899
Leadership
- Samuel Blackman, MD, PhD, Head of R&D
- Elly Barry, MD, Chief Medical Officer
- Jeremy Bender, PhD, MBA, Director
- Davy Chiodin, PharmD, Chief Development Officer
- Adam Dubow, General Counsel
- Lauren Merendino, MBA, Chief Commercial Officer
- John Stubenrauch, Chief Technology Officer
- Jaa Roberson, Chief People Officer
- Charles N. York II, MBA, Chief Operating and Financial Officer
- Garry Nicholson, MBA, Chair
- Habib Dable, Director
- Scott Garland, Director
- Michael Gladstone, Director
- William Grossman, MD, PhD, Director
- Natalie Holles, Director
- John A. Josey, PhD, MBA, Director
- Saira Ramasastry, MS, MPhil, Director
Last updated: 2024-12-31
Forte Biosciences, Inc.
FB-102
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.
Symbol: FBRX
Recent Price: $21.14
Industry: Biotechnology
CEO: Dr. Paul A. Wagner Ph.D.
Sector: Healthcare
Employees: 11
Address: 3060 Pegasus Park Drive, Dallas, TX 75247
Phone: 310 618 6994
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
Peak Bio, Inc.
PHP-303
Peak Bio, Inc., based in Palo Alto, California, is a clinical-stage biopharmaceutical company focusing on developing therapeutics for oncology and inflammation, with a lead product candidate, PHP-303, for orphan disease Alpha1 anti-trypsin deficiency.
Symbol: PKBO
Recent Price: $0.07
Industry: Biotechnology
CEO: Dr. Hoyoung Huh M.D., Ph.D.
Sector: Healthcare
Employees: 6
Address: 3350 W Bayshore Rd., Palo Alto, CA 94303
Phone: 650-549-9103
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Silo Pharma, Inc.
SPC-15
Silo Pharma Inc. is a developmental stage biopharmaceutical company focusing on treatments for stress-induced psychiatric disorders, chronic pain, and CNS diseases through traditional and psychedelic therapies.
Symbol: SILO
Recent Price: $0.89
Industry: Biotechnology
CEO: Mr. Eric Weisblum
Sector: Healthcare
Employees: 3
Address: 677 N. Washington Boulevard, Sarasota, FL 34236
Phone: 718 400 9031
Last updated: 2024-12-31
Third Harmonic Bio, Inc.
THB001
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.
Symbol: THRD
Recent Price: $10.38
Industry: Biotechnology
CEO: Ms. Natalie C. Holles
Sector: Healthcare
Employees: 42
Address: 300 Technology Square, Cambridge, MA 02139
Phone: 617-915-6680
Last updated: 2024-12-31
BridgeBio Pharma, Inc.
AG10, BBP-265, BBP-831, BBP-631, Encaleret
Bridge Bio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases, with a pipeline of 30 programs including candidates like AG10, BBP-265, and others in various stages of clinical trials.
About | About | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Management | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: BBIO
Recent Price: $27.32
Industry: Biotechnology
CEO: Dr. Neil Kumar Ph.D.
Sector: Healthcare
Employees: 550
Address: 421 Kipling Street, Palo Alto, CA 94301
Phone: 650 391 9740
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08